| Title : Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study - Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115 |
| Author(s) : Ghafary S , Najafi Z , Mohammadi-Khanaposhtani M , Nadri H , Edraki N , Ayashi N , Larijani B , Amini M , Mahdavi M |
| Ref : Arch Pharm (Weinheim) , 351 :e1800115 , 2018 |
| Abstract : Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115 |
| ESTHER : Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115 |
| PubMedSearch : Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115 |
| PubMedID: 30284339 |
Ghafary S, Najafi Z, Mohammadi-Khanaposhtani M, Nadri H, Edraki N, Ayashi N, Larijani B, Amini M, Mahdavi M (2018)
Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study
Arch Pharm (Weinheim)
351 :e1800115
Ghafary S, Najafi Z, Mohammadi-Khanaposhtani M, Nadri H, Edraki N, Ayashi N, Larijani B, Amini M, Mahdavi M (2018)
Arch Pharm (Weinheim)
351 :e1800115